Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hulett

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecular Immunology|October 4, 2005
Cell surface expression of a peptide encoded by the unrearranged TCR-Vbeta8.2 geneJanice L Abbey, Mark Hulett, Helen C O'Neill
The Journal of Experimental Medicine|February 5, 2003
Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent processJoerg Mattes, Mark Hulett, Wei Xie, et al.
Journal of Leukocyte Biology|May 30, 2006
ICAM-1-dependent pathways regulate colonic eosinophilic inflammationElizabeth Forbes, Mark Hulett, Richard Ahrens, et al.
BMJ Open|February 9, 2023
Trajectory of knee health in runners with and without heightened osteoarthritis risk: the TRAIL prospective cohort study protocolDanilo De Oliveira Silva, Richard T R Johnston, Benjamin F Mentiplay, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecular Immunology|October 4, 2005
Cell surface expression of a peptide encoded by the unrearranged TCR-Vbeta8.2 geneJanice L Abbey, Mark Hulett, Helen C O'Neill
The Journal of Experimental Medicine|February 5, 2003
Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent processJoerg Mattes, Mark Hulett, Wei Xie, et al.
Journal of Leukocyte Biology|May 30, 2006
ICAM-1-dependent pathways regulate colonic eosinophilic inflammationElizabeth Forbes, Mark Hulett, Richard Ahrens, et al.
BMJ Open|February 9, 2023
Trajectory of knee health in runners with and without heightened osteoarthritis risk: the TRAIL prospective cohort study protocolDanilo De Oliveira Silva, Richard T R Johnston, Benjamin F Mentiplay, et al.
Pageof 1